Earnings Preview: What To Expect From STERIS' Report STERIS is set to announce its second-quarter earnings in November, and analysts expect single-digit EPS growth. Barchart · Oct 23
STERIS Stock: Is STE Underperforming the Healthcare Sector? STERIS has trailed the broader market over the past year, while Wall Street analysts remain cautiously optimistic about the company’s future prospects. Barchart · Sep 16
STERIS Stock Outlook: Is Wall Street Bullish or Bearish? STERIS has lagged behind the broader market over the past year, and analysts remain somewhat bullish about the stock’s prospects. Barchart · Aug 26
Is STERIS Stock Underperforming the Dow? While STERIS has underperformed relative to the Dow over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects. Barchart · Jun 15
STERIS Q4 Earnings Call Highlights STERIS (NYSE:STE) reported a stronger fiscal 2026 overall despite a lighter fourth quarter, with executives pointing to record annual revenue, resilient procedure demand and continued pricing gains, while also outlining expectations for mid- to high-single-digit growth in fiscal 2027. Senior Vice P MarketBeat · May 15
7 Stocks Worth Buying the Dip in Now... Or At Least Adding to Your Watchlist While the S&P 500 notched another record close on Tuesday, 17 NYSE and Nasdaq Composite stocks fell to new 52-week lows. Here’s why the seven highest-priced names deserve a spot on your watchlist. Barchart · May 6
Is Wall Street Bullish or Bearish on STERIS Stock? Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects. Barchart · Feb 20
STERIS Earnings Preview: What to Expect STERIS is set to report its third-quarter earnings soon, and analysts are anticipating a single-digit growth in its bottom line. Barchart · Jan 8
Are Wall Street Analysts Bullish on STERIS Stock? Despite STERIS' outperformance relative to the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects. Barchart · Nov 20, 2025
What You Need to Know Ahead of STERIS’ Earnings Release STERIS is scheduled to release its second-quarter results next month, and analysts are anticipating a robust double-digit increase in earnings. Barchart · Oct 22, 2025
How Is STERIS’ Stock Performance Compared to Other Medical Devices Stocks? STERIS has outpaced its industry peers over the past year, and analysts are reasonably bullish on its future prospects. Barchart · Sep 17, 2025
What Are Wall Street Analysts' Target Price for STERIS Stock? While STERIS has underperformed the broader market over the past year, analysts are highly optimistic about the stock’s prospects. Barchart · Aug 27, 2025
STERIS Stock: Is STE Outperforming the Healthcare Sector? STERIS has outpaced the broader healthcare sector over the past year and analysts are reasonably bullish on its future prospects. Barchart · Jun 18, 2025
Is STERIS Stock Underperforming the Dow? Despite STERIS’ underperformance relative to Dow Jones over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects. Barchart · Mar 24, 2025
Barchart · Jan 14, 2025 Here's What to Expect from STERIS’ Next Earnings Report Healthcare major STERIS is expected to announce its third-quarter earnings in the upcoming month and analysts expect a modest single-digit growth in earnings.
Barchart · Dec 19, 2024 Is STERIS Stock Underperforming the Nasdaq? STERIS stock has significantly underperformed the Nasdaq over the past 52 weeks, yet analysts remain strongly bullish on the stock’s prospects.
Barchart · Sep 18, 2024 Is STERIS Stock Underperforming the S&P 500? STERIS has underperformed the S&P 500 over the past year, yet analysts remain moderately bullish about the stock’s potential.
StockNews.com · Sep 5, 2024 3 Healthcare Innovators Transforming Patient Care The healthcare industry's long-term growth is fueled by rising R&D initiatives and the adoption of cutting-edge technologies. Hence, it could be ideal to buy fundamentally solid medical device stocks Alcon (ALC), Becton, Dickinson and Company (BDX), and STERIS (STE) for potential returns. Keep reading.
Barchart · Aug 30, 2024 STERIS Stock Outlook: Is Wall Street Bullish or Bearish? STERIS has underperformed the broader market over the past year, yet analysts remain moderately bullish on the stock’s potential.
Bangkok Post · Jun 23, 2022 Please join “Business and Investment Opportunities in the Medical Sector in Thailand” Thailand Board of Investment (BOI), Paris Office, cordially invites companies to join its webinar on Business and Investment Opportunities in the Medical Sector in Thailand with BOI Headquarters, Bangkok Dusit Medical Service (BDMS), Thai Food and Drug Administration (FDA), Sanet Asean Advisors, and STERIS (AST)
Benzinga · Jun 17, 2022 Ominous Death Cross Forms On Steris's Chart If history is any guide, there may be trouble ahead for shares of Steris (NYSE:STE). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Benzinga · May 11, 2022 Steris: Q4 Earnings Insights Steris (NYSE:STE) reported its Q4 earnings results on Wednesday, May 11, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 0.99%, reporting an EPS of $2.04 versus an estimate of $2.02.
Benzinga · Feb 9, 2022 Steris Q3 Sales Jump 50% To $1.2B, Revises FY22 Guidance Steris plc (NYSE: STE)
Benzinga · Feb 8, 2022 Recap: Steris Q3 Earnings Steris (NYSE:STE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 04:30 PM. Here's what investors need to know about the announcement. Earnings Steris beat estimated earnings by 7.61%, reporting an EPS of $2.12 versus an estimate of $1.97.